๐๏ธ Verified NIH Record โข Updated 2026-06-15
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD) (NCT06906627)
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD)
๐ข Recruiting Observational / Diagnostic ๐ Clinical Research Protocol Sponsor: Duke University
๐ฉบ Plain-English Summary (8th-Grade Level)
IRIS-CKD is an implementation study to improve guideline-recommended screening of chronic kidney disease (CKD) in individuals with type 2 diabetes (T2D) in the United States.
Who can join: Review the eligibility criteria below.
Location: University of Alabama โ Birmingham, Alabama
Age range: 18 Years
๐งช Interventions in This Study
- (IRIS-CKD Screening Program): Home Kit (OTHER)
- (IRIS-CKD Screening Program): Standard Lab Order (OTHER)
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (7 Sites)
- University of Alabama โ Birmingham, Alabama
- Orlando Health โ St. Petersburg, Florida
- University of Michigan โ Ann Arbor, Michigan
- Essentia Health โ Duluth, Minnesota
- Duke University โ Durham, North Carolina
- Houston Methodist โ Houston, North Carolina
- Baylor Scott & White โ Temple, Texas
๐ Contact the Study Coordinator
Phone: (919) 668-7829
Email: gretchen.sanders@duke.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Chronic Kidney Disease(CKD)
- Effect of Oral Consumption of a Symbiotic Gelatin on the Presence of Gastrointestinal Symptoms and Quality of Life in People With Chronic Kidney Disease โ Toluca,
- Genomic First Testing in Chronic Kidney Disease โ London, Ontario
- Monocytes in Subjects With Type 1 Diabetes and Chronic Kidney Disease โ Cleveland, Ohio
- Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2) โ Birmingham, Alabama
- An Intervention to Reduce Sedentary Behavior for Adults With Chronic Kidney Disease โ Chicago, Illinois
Explore by condition: All Chronic Kidney Disease(CKD) clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.